Your browser doesn't support javascript.
loading
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes.
Fang, Shenying; Wang, Yuling; Dang, Yifang; Gagel, Andrew; Ross, Merrick I; Gershenwald, Jeffrey E; Cormier, Janice N; Wargo, Jennifer; Haydu, Lauren E; Davies, Michael A; McQuade, Jennifer L; Sui, Dawen; Bassett, Roland L; Reveille, John D; Wei, Qingyi; Amos, Christopher I; Lee, Jeffrey E.
Afiliación
  • Fang S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: sfang@mdanderson.org.
  • Wang Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dang Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gagel A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cormier JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sui D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bassett RL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reveille JD; Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Wei Q; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Amos CI; Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: jelee@mdanderson.org.
J Invest Dermatol ; 137(8): 1792-1795, 2017 08.
Article en En | MEDLINE | ID: mdl-28442307
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Índice de Masa Corporal / Medición de Riesgo / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Invest Dermatol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína C-Reactiva / Índice de Masa Corporal / Medición de Riesgo / Melanoma Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Invest Dermatol Año: 2017 Tipo del documento: Article